Searched for
ADITYA KHEMANI
Invesco’s ₹16,000 crore midcap fund delivered 426% return in 10 years. Aditya Khemani reveals the strategyInvesco India Midcap Fund has impressively delivered a 426% return over a decade, showcasing an investment strategy that values robust earn...- Invesco India Pharma and Healthcare Fund NFO is open for subscription. 7 key details to knowInvesco India Mutual Fund has launched its Pharma and Healthcare Fund, open until September 1. The thematic scheme will invest across pharm...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- NFO Alert: Invesco Mutual Fund announces launch of pharma and healthcare fundInvesco Mutual Fund has launched a new open-ended equity scheme. This fund will invest in India's evolving pharma and healthcare sectors. I...
- Markets to enter prolonged “drag phase,” not deep correction: Vikas KhemaniMarket expert Vikas Khemani anticipates a consolidation phase for Indian equities rather than a sharp breakout, citing persistent global ma...
- Why smallcap funds are still a buy: A long-term strategy from Aditya KhemaniSmallcap valuations seem high but underlying fundamentals have improved. Aditya Khemani of Invesco Mutual Fund sees this as a structural sh...
- War, falling markets, and a two-year window: Why Vikas Khemani is buying banks, aviation, and pharma right nowIndian markets are down, presenting a buying opportunity for long-term investors. Vikas Khemani of Carnelian Asset Management sees potentia...
- Vikas Khemani predicts 15–20% market gains this Samvat, says PSU banks and manufacturing to lead India’s next big bull runIndian equities are poised for a significant upswing, with Nifty projected to reach 29,000-30,000 this Samvat year, forecasting 15-20% retu...
- Omega bull run: Mid, smallcaps to outperform for 5-10 years; largecaps also do well: Vikas KhemaniVikas Khemani, Founder of Carnelian Asset Advisors, discusses the mantra of faster, stronger, cheaper for portfolio growth. He believes tha...
- This mid-cap equity mutual fund gave 29.2% returns in 3 years; should you invest?INVESCO INDIA MID CAP: The fund’s preference is for growth-oriented, niche businesses, with strong cash flows, healthy balance sheets and m...
- Invesco India Small Cap mutual fund's risk-return profile not among the best in the categoryWe examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.
- Invesco Mutual Fund changes fund managers for three schemesThe fund house also informed that all other terms and conditions of the SIDs, KIMs and SAIs of the schemes will remain unchanged. This adde...
- Motilal Oswal Large & Mid cap mutual fund has sharply outperformed in past one year; should you invest?We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.
- Motilal Oswal Long Term Equity mutual fund review: Has exhibited bouts of sharp outperformanceThis tax-saving fund takes a flexi cap approach but retains a slight tilt towards large-caps, like many of its peers. However, it prefers t...
- Bigger money will be made in top 4 private banks over next 12 months: Aditya Khemani'The market correction today is a part of overall profit-booking exercise.'
- Among Covid winners, diagnostic and cement are long-term plays: Aditya KhemaniEven though there could be a bit of pent up demand, we need to take it with a pinch of salt.
- Expect pharma stocks to give 15% compounding returns over medium to long-term: Aditya Khemani‘I will be very positive on financials as a space over the next 12 months’
- Avoid OMC stocks if you are a long-term investor: Aditya Khemani‘Policy framework has not been very certain in government-owned OMCs’
- Motilal Oswal AMC launches a large & mid cap fundMotilal Oswal Large and Midcap Fund is a concentrated portfolio of around 20-25 stocks.
- Vikas Khemani: For this go-getter deal maker, there are no short cutsOver the past decade, he’s built several of them for Edelweiss from scratch -- futures and derivatives, institutional and later local broke...
Load More
